US Physicalrapy Net Worth
US Physicalrapy Net Worth Breakdown | USPH |
US Physicalrapy Net Worth Analysis
US Physicalrapy's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including US Physicalrapy's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of US Physicalrapy's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform US Physicalrapy's net worth analysis. One common approach is to calculate US Physicalrapy's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares US Physicalrapy's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing US Physicalrapy's net worth. This approach calculates the present value of US Physicalrapy's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of US Physicalrapy's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate US Physicalrapy's net worth. This involves comparing US Physicalrapy's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into US Physicalrapy's net worth relative to its peers.
Enterprise Value |
|
To determine if US Physicalrapy is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding US Physicalrapy's net worth research are outlined below:
| US Physicalrapy generated a negative expected return over the last 90 days | |
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Outpatient Specialty Care Stocks Q4 Results Benchmarking U.S. Physical Therapy |
US Physicalrapy Quarterly Good Will |
|
US Physicalrapy uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in US Physicalrapy. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to US Physicalrapy's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
US Physicalrapy Target Price Consensus
USPH target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. US Physicalrapy's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most USPH analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand USPH stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of US Physicalrapy, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationUS Physicalrapy Target Price Projection
US Physicalrapy's current and average target prices are 76.04 and 111.33, respectively. The current price of US Physicalrapy is the price at which US Physicalrapy is currently trading. On the other hand, US Physicalrapy's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
US Physicalrapy Market Quote on 20th of March 2025
Target Price
Analyst Consensus On US Physicalrapy Target Price
Know US Physicalrapy's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as US Physicalrapy is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading US Physicalrapy backward and forwards among themselves. US Physicalrapy's institutional investor refers to the entity that pools money to purchase US Physicalrapy's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Gw&k Investment Management, Llc | 2024-12-31 | 316.2 K | Riverbridge Partners Llc | 2024-12-31 | 310.2 K | Envestnet Asset Management Inc | 2024-12-31 | 299.8 K | Northern Trust Corp | 2024-12-31 | 261.8 K | Bahl & Gaynor Inc. | 2024-12-31 | 260.1 K | Point72 Asset Management, L.p. | 2024-12-31 | 212.9 K | Silvercrest Asset Management Group Llc | 2024-12-31 | 189.1 K | Rockefeller Capital Management L.p. | 2024-12-31 | 188.3 K | Fmr Inc | 2024-12-31 | 165.7 K | Blackrock Inc | 2024-12-31 | 2.3 M | Vanguard Group Inc | 2024-12-31 | 1.1 M |
Follow US Physicalrapy's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.16 B.Market Cap |
|
Project US Physicalrapy's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.12 | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.08 |
When accessing US Physicalrapy's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures US Physicalrapy's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of US Physicalrapy's profitability and make more informed investment decisions.
Evaluate US Physicalrapy's management efficiency
US Physicalrapy has return on total asset (ROA) of 0.0404 % which means that it generated a profit of $0.0404 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0646 %, meaning that it created $0.0646 on every $100 dollars invested by stockholders. US Physicalrapy's management efficiency ratios could be used to measure how well US Physicalrapy manages its routine affairs as well as how well it operates its assets and liabilities. As of now, US Physicalrapy's Return On Tangible Assets are decreasing as compared to previous years. The US Physicalrapy's current Return On Equity is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.06. As of now, US Physicalrapy's Non Currrent Assets Other are decreasing as compared to previous years. The US Physicalrapy's current Intangible Assets is estimated to increase to about 188.3 M, while Other Current Assets are projected to decrease to under 5.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 50.39 | 52.91 | |
| Tangible Book Value Per Share | (5.80) | (5.51) | |
| Enterprise Value Over EBITDA | 16.67 | 17.50 | |
| Price Book Value Ratio | 2.73 | 4.65 | |
| Enterprise Value Multiple | 16.67 | 17.50 | |
| Price Fair Value | 2.73 | 4.65 | |
| Enterprise Value | 144.3 M | 151.5 M |
Effective leadership at US Physicalrapy drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 2.1018 | Revenue | Quarterly Revenue Growth 0.166 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific US Physicalrapy insiders, such as employees or executives, is commonly permitted as long as it does not rely on US Physicalrapy's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases US Physicalrapy insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
US Physicalrapy Corporate Filings
F4 | 18th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 7th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of February 2025 Other Reports | ViewVerify | |
| 24th of January 2025 Other Reports | ViewVerify |
US Physicalrapy Earnings Estimation Breakdown
The calculation of US Physicalrapy's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of US Physicalrapy is estimated to be 0.416 with the future projection ranging from a low of 0.34 to a high of 0.56. Please be aware that this consensus of annual earnings estimates for US Physicalrapy is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.34 Lowest | Expected EPS | 0.56 Highest |
US Physicalrapy Earnings Projection Consensus
Suppose the current estimates of US Physicalrapy's value are higher than the current market price of the US Physicalrapy stock. In this case, investors may conclude that US Physicalrapy is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and US Physicalrapy's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 7 | 93.11% | 0.51 | 0.416 | 1.84 |
US Physicalrapy Earnings History
Earnings estimate consensus by US Physicalrapy analysts from Wall Street is used by the market to judge US Physicalrapy's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only US Physicalrapy's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.US Physicalrapy Quarterly Gross Profit |
|
US Physicalrapy Earnings per Share Projection vs Actual
Actual Earning per Share of US Physicalrapy refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering US Physicalrapy predict the company's earnings will be in the future. The higher the earnings per share of US Physicalrapy, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.US Physicalrapy Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as US Physicalrapy, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of US Physicalrapy should always be considered in relation to other companies to make a more educated investment decision.USPH Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact US Physicalrapy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-26 | 2024-12-31 | 0.6965 | 0.51 | -0.1865 | 26 | ||
2024-11-05 | 2024-09-30 | 0.68 | 0.69 | 0.01 | 1 | ||
2024-08-13 | 2024-06-30 | 0.82 | 0.73 | -0.09 | 10 | ||
2024-05-07 | 2024-03-31 | 0.56 | 0.51 | -0.05 | 8 | ||
2024-02-28 | 2023-12-31 | 0.57 | 0.59 | 0.02 | 3 | ||
2023-11-07 | 2023-09-30 | 0.62 | 0.62 | 0.0 | 0 | ||
2023-08-08 | 2023-06-30 | 0.75 | 0.76 | 0.01 | 1 | ||
2023-05-03 | 2023-03-31 | 0.55 | 0.59 | 0.04 | 7 | ||
2023-02-22 | 2022-12-31 | 0.57 | 0.58 | 0.01 | 1 | ||
2022-11-02 | 2022-09-30 | 0.56 | 0.58 | 0.02 | 3 | ||
2022-08-04 | 2022-06-30 | 0.95 | 0.9 | -0.05 | 5 | ||
2022-05-05 | 2022-03-31 | 0.63 | 0.65 | 0.02 | 3 | ||
2022-02-24 | 2021-12-31 | 0.69 | 0.72 | 0.03 | 4 | ||
2021-11-04 | 2021-09-30 | 0.78 | 0.85 | 0.07 | 8 | ||
2021-08-05 | 2021-06-30 | 0.73 | 0.96 | 0.23 | 31 | ||
2021-05-06 | 2021-03-31 | 0.47 | 0.64 | 0.17 | 36 | ||
2021-02-25 | 2020-12-31 | 0.83 | 0.85 | 0.02 | 2 | ||
2020-11-05 | 2020-09-30 | 0.51 | 0.85 | 0.34 | 66 | ||
2020-08-06 | 2020-06-30 | -0.18 | 0.85 | 1.03 | 572 | ||
2020-05-21 | 2020-03-31 | 0.4 | 0.3 | -0.1 | 25 | ||
2020-02-27 | 2019-12-31 | 0.69 | 0.64 | -0.05 | 7 | ||
2019-11-07 | 2019-09-30 | 0.71 | 0.71 | 0.0 | 0 | ||
2019-08-08 | 2019-06-30 | 0.81 | 0.81 | 0.0 | 0 | ||
2019-05-02 | 2019-03-31 | 0.6 | 0.66 | 0.06 | 10 | ||
2019-03-07 | 2018-12-31 | 0.63 | 0.71 | 0.08 | 12 | ||
2018-11-01 | 2018-09-30 | 0.58 | 0.64 | 0.06 | 10 | ||
2018-08-02 | 2018-06-30 | 0.68 | 0.73 | 0.05 | 7 | ||
2018-05-03 | 2018-03-31 | 0.56 | 0.56 | 0.0 | 0 | ||
2018-03-08 | 2017-12-31 | 0.47 | 0.49 | 0.02 | 4 | ||
2017-11-02 | 2017-09-30 | 0.49 | 0.51 | 0.02 | 4 | ||
2017-08-03 | 2017-06-30 | 0.59 | 0.59 | 0.0 | 0 | ||
2017-06-07 | 2017-03-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2017-03-02 | 2016-12-31 | 0.47 | 0.46 | -0.01 | 2 | ||
2016-11-03 | 2016-09-30 | 0.49 | 0.46 | -0.03 | 6 | ||
2016-08-04 | 2016-06-30 | 0.55 | 0.57 | 0.02 | 3 | ||
2016-05-05 | 2016-03-31 | 0.39 | 0.43 | 0.04 | 10 | ||
2016-03-03 | 2015-12-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2015-11-05 | 2015-09-30 | 0.48 | 0.47 | -0.01 | 2 | ||
2015-08-06 | 2015-06-30 | 0.58 | 0.48 | -0.1 | 17 | ||
2015-05-07 | 2015-03-31 | 0.35 | 0.34 | -0.01 | 2 | ||
2015-03-05 | 2014-12-31 | 0.4 | 0.41 | 0.01 | 2 | ||
2014-11-06 | 2014-09-30 | 0.42 | 0.43 | 0.01 | 2 | ||
2014-08-07 | 2014-06-30 | 0.44 | 0.52 | 0.08 | 18 | ||
2014-05-08 | 2014-03-31 | 0.3 | 0.27 | -0.03 | 10 | ||
2014-03-06 | 2013-12-31 | 0.35 | 0.32 | -0.03 | 8 | ||
2013-11-07 | 2013-09-30 | 0.4 | 0.38 | -0.02 | 5 | ||
2013-08-08 | 2013-06-30 | 0.42 | 0.41 | -0.01 | 2 | ||
2013-05-09 | 2013-03-31 | 0.33 | 0.31 | -0.02 | 6 | ||
2013-03-07 | 2012-12-31 | 0.33 | 0.34 | 0.01 | 3 | ||
2012-11-08 | 2012-09-30 | 0.38 | 0.39 | 0.01 | 2 | ||
2012-08-09 | 2012-06-30 | 0.44 | 0.41 | -0.03 | 6 | ||
2012-05-03 | 2012-03-31 | 0.34 | 0.38 | 0.04 | 11 | ||
2012-03-08 | 2011-12-31 | 0.28 | 0.29 | 0.01 | 3 | ||
2011-11-03 | 2011-09-30 | 0.36 | 0.38 | 0.02 | 5 | ||
2011-08-04 | 2011-06-30 | 0.41 | 0.41 | 0.0 | 0 | ||
2011-05-05 | 2011-03-31 | 0.27 | 0.31 | 0.04 | 14 | ||
2011-03-03 | 2010-12-31 | 0.25 | 0.28 | 0.03 | 12 | ||
2010-11-04 | 2010-09-30 | 0.31 | 0.33 | 0.02 | 6 | ||
2010-08-05 | 2010-06-30 | 0.36 | 0.38 | 0.02 | 5 | ||
2010-05-06 | 2010-03-31 | 0.23 | 0.25 | 0.02 | 8 | ||
2010-03-04 | 2009-12-31 | 0.2 | 0.19 | -0.01 | 5 | ||
2009-11-05 | 2009-09-30 | 0.24 | 0.26 | 0.02 | 8 | ||
2009-08-06 | 2009-06-30 | 0.31 | 0.31 | 0.0 | 0 | ||
2009-05-07 | 2009-03-31 | 0.2 | 0.23 | 0.03 | 15 | ||
2009-03-05 | 2008-12-31 | 0.2 | 0.19 | -0.01 | 5 | ||
2008-11-06 | 2008-09-30 | 0.22 | 0.21 | -0.01 | 4 | ||
2008-08-07 | 2008-06-30 | 0.23 | 0.24 | 0.01 | 4 | ||
2008-05-08 | 2008-03-31 | 0.2 | 0.2 | 0.0 | 0 | ||
2008-03-06 | 2007-12-31 | 0.18 | 0.21 | 0.03 | 16 | ||
2007-11-08 | 2007-09-30 | 0.18 | 0.18 | 0.0 | 0 | ||
2007-08-02 | 2007-06-30 | 0.2 | 0.2 | 0.0 | 0 | ||
2007-05-03 | 2007-03-31 | 0.15 | 0.16 | 0.01 | 6 | ||
2007-03-16 | 2006-12-31 | 0.15 | 0.18 | 0.03 | 20 | ||
2006-11-02 | 2006-09-30 | 0.16 | 0.16 | 0.0 | 0 | ||
2006-08-01 | 2006-06-30 | 0.18 | 0.18 | 0.0 | 0 | ||
2006-05-04 | 2006-03-31 | 0.18 | 0.12 | -0.06 | 33 | ||
2006-03-02 | 2005-12-31 | 0.19 | 0.14 | -0.05 | 26 | ||
2005-10-27 | 2005-09-30 | 0.18 | 0.2 | 0.02 | 11 | ||
2005-08-02 | 2005-06-30 | 0.2 | 0.23 | 0.03 | 15 | ||
2005-04-28 | 2005-03-31 | 0.15 | 0.17 | 0.02 | 13 | ||
2005-03-03 | 2004-12-31 | 0.15 | 0.15 | 0.0 | 0 | ||
2004-10-27 | 2004-09-30 | 0.18 | 0.14 | -0.04 | 22 | ||
2004-07-29 | 2004-06-30 | 0.16 | 0.2 | 0.04 | 25 | ||
2004-04-29 | 2004-03-31 | 0.13 | 0.13 | 0.0 | 0 | ||
2004-03-04 | 2003-12-31 | 0.11 | 0.12 | 0.01 | 9 | ||
2003-10-30 | 2003-09-30 | 0.14 | 0.15 | 0.01 | 7 | ||
2003-07-31 | 2003-06-30 | 0.18 | 0.18 | 0.0 | 0 | ||
2003-04-30 | 2003-03-31 | 0.16 | 0.15 | -0.01 | 6 | ||
2003-02-27 | 2002-12-31 | 0.16 | 0.17 | 0.01 | 6 | ||
2002-11-08 | 2002-09-30 | 0.15 | 0.16 | 0.01 | 6 | ||
2002-08-01 | 2002-06-30 | 0.17 | 0.18 | 0.01 | 5 | ||
2002-05-01 | 2002-03-31 | 0.18 | 0.16 | -0.02 | 11 | ||
2001-08-02 | 2001-06-30 | 0.11 | 0.14 | 0.03 | 27 | ||
2001-03-09 | 2000-12-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2000-11-08 | 2000-09-30 | 0.08 | 0.1 | 0.02 | 25 | ||
2000-08-14 | 2000-06-30 | 0.07 | 0.09 | 0.02 | 28 | ||
2000-05-15 | 2000-03-31 | 0.06 | 0.08 | 0.02 | 33 | ||
2000-02-28 | 1999-12-31 | 0.06 | 0.06 | 0.0 | 0 | ||
1999-11-10 | 1999-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1999-08-05 | 1999-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
1998-11-13 | 1998-09-30 | 0.04 | 0.04 | 0.0 | 0 | ||
1998-08-05 | 1998-06-30 | 0.05 | 0.05 | 0.0 | 0 | ||
1998-06-26 | 1998-03-31 | 0.04 | 0.04 | 0.0 | 0 | ||
1998-03-17 | 1997-12-31 | 0.03 | 0.06 | 0.03 | 100 | ||
1997-11-07 | 1997-09-30 | 0.04 | 0.07 | 0.03 | 75 | ||
1997-08-07 | 1997-06-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1997-05-13 | 1997-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
1997-03-19 | 1996-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
1996-11-06 | 1996-09-30 | 0.04 | 0.05 | 0.01 | 25 |
US Physicalrapy Corporate Directors
| Mark Brookner | Independent Director | Profile | |
| Kathleen Gilmartin | Independent Director | Profile | |
| Clayton Trier | Independent Director | Profile | |
| Bernard Harris | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.76 | Earnings Share 1.84 | Revenue Per Share | Quarterly Revenue Growth 0.166 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.